share_log

南京证券股份有限公司关于南京麦澜德医疗科技股份有限公司2023年度持续督导跟踪报告

Nanjing Securities Co., Ltd.'s 2023 Continuous Supervision and Follow-up Report on Nanjing Mailland Medical Technology Co., Ltd.

Sensex a share ·  Apr 30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more